MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO ...
ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in ...
The main market opportunity lies in the need for comprehensive GMP audits in the pharmaceutical industry. By integrating interviews with traditional methods, such audits provide deeper insights into ...
Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, today announced the launch of NB-Lux™ AI, a next-generation digital ...
MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, ...
Exporters continue to face delay in issuance of WHO GMP CoPP through ONDLS online platform: Shardul Nautiyal, Mumbai Tuesday, May 12, 2026, 08:00 Hrs [IST] Pharma exporters are co ...
Manufacturers are usually subjected to a diverse variety of regulations typically established by international and regional bodies. Failure to comply can result in the loss of authorization and ...
Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results